September 2016 Member Publications

September Total (53 total)

1.     Novel Therapies for Familial Hypercholesterolemia. Parizo J, Sarraju A, Knowles JW. Curr Treat Options Cardiovasc Med. 2016 Nov;18(11):64.

2.     Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): A phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and tolerability of CSL112, a reconstituted, infusible, human apoA-I, after acute myocardial infarction. Gibson CM, Korjian S, Tricoci P, Daaboul Y, Alexander JH, Steg PG, Lincoff AM, Kastelein JJ, Mehran R, D'Andrea D, Merkely B, Zarebinski M, Ophius TO, Harrington RA. Am Heart J. 2016 Oct;180:22-8.

3.     NETs Activate Pulmonary Arterial Endothelial Cells. Rabinovitch M. Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2035-7.

4.     Romidepsin for the treatment of relapsed/refractory cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome): Use in a community setting. Reddy SA. Crit Rev Oncol Hematol. 2016 Oct;106:99-107.

5.     Genetics and Genomics of Coronary Artery Disease. Pjanic M, Miller CL, Wirka R, Kim JB, DiRenzo DM, Quertermous T. Curr Cardiol Rep. 2016 Oct;18(10):102.

6.     Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX Trial. Abtan J, Steg PG, Stone GW, Mahaffey KW, Gibson CM, Hamm CW, Price MJ, Abnousi F, Prats J, Deliargyris EN, White HD, Harrington RA, Bhatt DL; CHAMPION PHOENIX Investigators. JACC Cardiovasc Interv. 2016 Sep 26;9(18):1905-13.

7.     Is There a Difference in Tachycardia Cycle Length During SVT in Children with AVRT and AVNRT? Mills MF, Motonaga KS, Trela A, Dubin AM, Avasarala K, Ceresnak SR. Pacing Clin Electrophysiol. 2016 Sep 22. doi: 10.1111/pace.12950.

8.     Near-infrared spectroscopy for detection of a significant patent ductus arteriosus. Chock VY, Rose LA, Mante JV, Punn R. Pediatr Res. 2016 Sep 21.

9.     High-Resolution Analysis of Antibodies to Post-Translational Modifications Using Peptide Nanosensor Microarrays. Lee JR, Haddon DJ, Gupta N, Price JV, Credo GM, Diep VK, Kim K, Hall DA, Baechler EC, Petri M, Varma M, Utz PJ, Wang SX. ACS Nano. 2016 Sep 20.

10. Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension. Bonnet S, Provencher S, Guignabert C, Perros F, Boucherat O, Schermuly RT, Hassoun PM, Rabinovitch M, Nicolls MR, Humbert M. Am J Respir Crit Care Med. 2016 Sep 20.

11. Predicting inpatient clinical order patterns with probabilistic topic models vs conventional order sets. Chen JH, Goldstein MK, Asch SM, Mackey L, Altman RB. J Am Med Inform Assoc. 2016 Sep 20.

12. Pro-inflammatory and anti-inflammatory T cells in giant cell arteritis. Watanabe R, Hosgur E, Zhang H, Wen Z, Berry G, Goronzy JJ, Weyand CM. Joint Bone Spine. 2016 Sep 20.

13. GIS-measured walkability, transit, and recreation environments in relation to older Adults'physical activity: A latent profile analysis. Todd M, Adams MA, Kurka J, Conway TL, Cain KL, Buman MP, Frank LD, Sallis JF, King AC. Prev Med. 2016 Sep 20.

14. Pathological Ace2-to-Ace enzyme switch in the stressed heart is transcriptionally controlled by the endothelial Brg1-FoxM1 complex. Yang J, Feng X, Zhou Q, Cheng W, Shang C, Han P, Lin CH, Chen HS, Quertermous T, Chang CP. Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):E5628-35.

15. Decompressing vein and bilateral superior venae cavae in a patient with hypoplastic left heart syndrome. Stauffer KJ, Arunamata A, Vasanawala SS, Behera SK, Kipps AK, Silverman NH. Echocardiography. 2016 Sep 19.

16. iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy. Kodo K, Ong SG, Jahanbani F, Termglinchan V, Hirono K, InanlooRahatloo K, Ebert AD, Shukla P, Abilez OJ, Churko JM, Karakikes I, Jung G, Ichida F, Wu SM, Snyder MP, Bernstein D, Wu JC. Nat Cell Biol. 2016 Sep 19.

17. Engineered knottin peptides as diagnostics, therapeutics, and drug delivery vehicles. Kintzing JR, Cochran JR. Curr Opin Chem Biol. 2016 Sep 16;34:143-150.

18. Challenging the complementarity of different metrics of left atrial function: insight from a cardiomyopathy-based study. Kobayashi Y, Moneghetti KJ, Boralkar K, Amsallem M, Tuzovic M, Liang D, Yang PC, Narayan S, Kuznetsova T, Wu JC, Schnittger I, Haddad F. Eur Heart J Cardiovasc Imaging. 2016 Sep 16.

19. Use of the triglyceride/high-density lipoprotein cholesterol ratio to identify cardiometabolic risk: impact of obesity? Salazar MR, Carbajal HA, Espeche WG, Aizpurúa M, Marillet AG, Leiva Sisnieguez CE, Leiva Sisnieguez BC, Stavile RN, March CE, Reaven GM. J Investig Med. 2016 Sep 16.

20. Precision medicine: Fantasy meets reality. Shrager J. Science. 2016 Sep 16;353(6305):1216-7.

21. Effect of cardiac resynchronization therapy on the risk of ventricular tachyarrhythmias in patients with chronic kidney disease. Daimee UA, Biton Y, Moss AJ, Zareba W, Cannom D, Klein H, Solomon S, Ruwald MH, McNitt S, Polonsky B, Wang PJ, Goldenberg I, Kutyifa V. Ann Noninvasive Electrocardiol. 2016 Sep 15.

22. Challenges and opportunities in limiting abdominal aortic aneurysm growth. Golledge J, Norman PE, Murphy MP, Dalman RL. J Vasc Surg. 2016 Sep 15.

23. PharmGKB summary: ivacaftor pathway, pharmacokinetics/pharmacodynamics. Fohner AE, McDonagh EM, Clancy JP, Whirl Carrillo M, Altman RB, Klein TE. Pharmacogenet Genomics. 2016 Sep 15.

24. Partial LVAD restores ventricular outputs and normalizes LV but not RV stress distributions in the acutely failing heart in silico. Sack KL, Baillargeon B, Acevedo-Bolton G, Genet M, Rebelo N, Kuhl E, Klein L, Weiselthaler GM, Burkhoff D, Franz T, Guccione JM. Int J Artif Organs. 2016 Sep 14:0.

25. Fractional Flow Reserve in Acute Coronary Syndromes. Fearon WF, De Bruyne B, Pijls NH. J Am Coll Cardiol. 2016 Sep 13;68(11):1192-4.

26. Microembolization is associated with transient cognitive decline in patients undergoing carotid interventions. Hitchner E, Baughman BD, Soman S, Long B, Rosen A, Zhou W. J Vasc Surg. 2016 Sep 12.

27. ChIA-PET2: a versatile and flexible pipeline for ChIA-PET data analysis. Li G, Chen Y, Snyder MP, Zhang MQ. Nucleic Acids Res. 2016 Sep 12.

28. Generation of Functional Cardiomyocytes from the Synoviocytes of Patients with Rheumatoid Arthritis via Induced Pluripotent Stem Cells. Lee J, Jung SM, Ebert AD, Wu H, Diecke S, Kim Y, Yi H, Park SH, Ju JH. Sci Rep. 2016 Sep 9;6:32669.

29. Development of a Mobile Tool That Semiautomatically Screens Patients for Stroke Clinical Trials. Spokoyny I, Lansberg M, Thiessen R, Kemp SM, Aksoy D, Lee Y, Mlynash M, Hirsch KG. Stroke. 2016 Sep 8.

30. Imaging approaches to optimize molecular therapies. Weissleder R, Schwaiger MC, Gambhir SS, Hricak H. Sci Transl Med. 2016 Sep 7;8(355):355ps16.

31. Modified High Molecular Weight Hyaluronan Promotes Allergen-Specific Immune Tolerance. Gebe JA, Yadava K, Ruppert SM, Marshall P, Hill P, Falk BA, Sweere JM, Han H, Kaber G, Medina C, Mikecz K, Ziegler SF, Balaji S, Keswani SG, de Jesus Perez VA, Butte MJ, Nadeau K, Altemeier WA, Fanger N, Bollyky PL. Am J Respir Cell Mol Biol. 2016 Sep 6.

32. Cardiac subtype characterization using all-optical action potential imaging. Shukla P, Wu JC. Eur Heart J. 2016 Sep 4.

33. Dual-Stage Crosslinking of a Gel-Phase Bioink Improves Cell Viability and Homogeneity for 3D Bioprinting. Dubbin K, Hori Y, Lewis KK, Heilshorn SC. Adv Healthc Mater. 2016 Sep 1.

34. Bone marrow cell characteristics associated with patient profile and cardiac performance outcomes in the LateTIME-Cardiovascular Cell Therapy Research Network (CCTRN) trial. Bhatnagar A, Bolli R, Johnstone BH, Traverse JH, Henry TD, Pepine CJ, Willerson JT, Perin EC, Ellis SG, Zhao DX, Yang PC, Cooke JP, Schutt RC, Trachtenberg BH, Orozco A, Resende M, Ebert RF, Sayre SL, Simari RD, Moyé L, Cogle CR, Taylor DA; Cardiovascular Cell Therapy Research Network (CCTRN). Am Heart J. 2016 Sep;179:142-50.

35. Heart failure medications prescribed at discharge for patients with left ventricular assist devices. Shreibati JB, Sheng S, Fonarow GC, DeVore AD, Yancy CW, Bhatt DL, Schulte P, Peterson ED, Hernandez A, Heidenreich PA. Am Heart J. 2016 Sep;179:99-106.

36. Progressive intermediate-term improvement in ventricular and atrioventricular interaction after transcatheter pulmonary valve replacement in patients with right ventricular outflow tract obstruction. Lunze FI, Hasan BS, Gauvreau K, Brown DW, Colan SD, McElhinney DB. Am Heart J. 2016 Sep;179:87-98.

37. Use of concomitant aspirin in patients with atrial fibrillation: Findings from the ROCKET AF trial. Shah R, Hellkamp A, Lokhnygina Y, Becker RC, Berkowitz SD, Breithardt G, Hacke W, Halperin JL, Hankey GJ, Fox KA, Nessel CC, Mahaffey KW, Piccini JP, Singer DE, Patel MR; ROCKET AF Steering Committee Investigators. Am Heart J. 2016 Sep;179:77-86.

38. Silver-Impregnated Dressings for Sternotomy Incisions to Prevent Surgical Site Infections in Children. Staveski S, Abrajano C, Casazza M, Bair E, Quan H, Dong E, Petty A, Felix K, Roth SJ. Am J Crit Care. 2016 Sep;25(5):402-8.

39. Cell transplantation in heart failure: where do we stand in 2016? MacArthur JW, Goldstone AB, Cohen JE, Hiesinger W, Woo YJ. Eur J Cardiothorac Surg. 2016 Sep;50(3):396-9.

40. Wnt pathway regulation of intestinal stem cells. Mah AT, Yan KS, Kuo CJ. J Physiol. 2016 Sep 1;594(17):4837-47.

41. Lymphedema Is a Disease of the Skin. Rockson SG. Lymphat Res Biol. 2016 Sep;14(3):123.

42. Population-specific single-nucleotide polymorphism confers increased risk of venous thromboembolism in African Americans. Daneshjou R, Cavallari LH, Weeke PE, Karczewski KJ, Drozda K, Perera MA, Johnson JA, Klein TE, Bustamante CD, Roden DM, Shaffer C, Denny JC, Zehnder JL, Altman RB. Mol Genet Genomic Med. 2016 Jun 21;4(5):513-20.

43. Aldehyde dehydrogenase 2 in aplastic anemia, Fanconi anemia and hematopoietic stem cells. Van Wassenhove LD, Mochly-Rosen D, Weinberg KI. Mol Genet Metab. 2016 Sep;119(1-2):28-36.

44. In vivo Post-Cardiac Arrest Myocardial Dysfunction is Supported by CaMKII-Mediated Calcium Long-Term Potentiation and Mitigated by Alda-1, an Agonist of Aldehyde Dehydrogenase Type 2. Woods C, Shang C, Taghavi F, Downey P, Zalewski A, Rubio G, Liu J, Homburger J, Grunwald Z, Qi W, Bollensdorff C, Thanaporn P, Ali A, Riemer RK, Kohl P, Mochly Rosen D, Gerstenfeld E, Large S, Ali Z, Ashley E. Circulation. 2016 Aug 31.

45. The Outlook of Digital Health for Cardiovascular Medicine: Challenges but Also Extraordinary Opportunities. Turakhia MP, Desai SA, Harrington RA. JAMA Cardiol. 2016 Aug 31.

46. Potential Strategies to Address the Major Clinical Barriers Facing Stem Cell Regenerative Therapy for Cardiovascular Disease: A Review. Nguyen PK, Neofytou E, Rhee JW, Wu JC. JAMA Cardiol. 2016 Aug 31.

47. Subacute left ventricular outflow tract obstruction after transapical closure of a mitral paravalvular leak in the region of the aortomitral curtain. Chikkabyrappa S, McElhinney DB, Saric M. Echocardiography. 2016 Aug 30.

48. "Off-Hours" Versus "On-Hours" Presentation in ST-Segment Elevation Myocardial Infarction: Findings from CHAMPION PHOENIX. Selvaraj S, Bhatt DL, Stone GW, Gibson CM, Steg PG, Hamm CW, Price MJ, Deliargyris EN, Prats J, Mahaffey KW, White HD, Harrington RA; CHAMPION PHOENIX Investigators. J Am Coll Cardiol. 2016 Aug 25.

49. Non-myeloablative preconditioning with ACK2 (anti-c-kit antibody) is efficient in bone marrow transplantation for murine models of mucopolysaccharidosis type II. Yokoi T, Yokoi K, Akiyama K, Higuchi T, Shimada Y, Kobayashi H, Sato T, Ohteki T, Otsu M, Nakauchi H, Ida H, Ohashi T. Mol Genet Metab. 2016 Aug 21.

50. Depressive Symptoms, Cardiac Disease Severity, and Functional Status in Patients With Coronary Artery Disease (from the Heart and Soul Study). Schopfer DW, Regan M, Heidenreich PA, Whooley MA. Am J Cardiol. 2016 Aug 12.

51. Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials). Kohli P, Knowles JW, Sarraju A, Waters DD, Reaven G. Am J Cardiol. 2016 Aug 12.

52. Cost-Effectiveness of Cardiac Radiosurgery for Atrial Fibrillation: Implications for Reducing Health Care Morbidity, Utilization, and Costs. Bhatt N, Turakhia M, Fogarty TJ. Cureus. 2016 Aug 1;8(8):e720.

53. Serum Cytokines in Young Pediatric Patients with Congenital Cardiac Shunts and Altered Pulmonary Hemodynamics. Zorzanelli L, Maeda NY, Clavé MM, Aiello VD, Rabinovitch M, Lopes AA. Mediators Inflamm. 2016;2016:7672048. Epub 2016 Aug 30.